Vivek Nanda

2.3k citations
26 papers · 1.3k · 1 hit paper · h-index 12

Impact in

  • Immunology top 5%
    • Phagocytosis and Immune Regulation
    • Atherosclerosis and Cardiovascular Diseases
    • Immune cells in cancer
    • Cancer-related molecular mechanisms research

Papers in

    • RNA Research and Splicing 3
    • Coenzyme Q10 studies and effects 3
    • RNA modifications and cancer 3
    • Genomics, phytochemicals, and oxidative stress 2
    • Single-cell and spatial transcriptomics 2
    • Extracellular vesicles in disease 2

Vivek Nanda

24 papers receiving 1.3k citations

Vivek Nanda's Hit Papers

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis 2016 · 515 citations
5150+3+6Years since publication100200300400500

Peers

Vivek Nanda
Comparison fields: 5 of 105
  • Immunology 562
  • Cancer Research 273
  • Molecular Biology 552
  • Immunology and Allergy 31
  • Cardiology and Cardiovascular Medicine 109
Replace Francisco Caiado with:
Francisco Caiado Switzerland
Esther Elishaev United States
Sergio Caja Finland
Zachary S. Buchwald United States
Jenny Yao United States
Qi‐Quan Huang United States
Jakub Toczek United States
Anastasia Chillà Italy
Siyeon Rhee United States
Maria De Pizzol Italy
Vivek Nanda relative to Francisco Caiado Switzerland Francisco Caiado's profile →
Citations per field
00.5×2×3×4×4.5×
Francisco Caiado · 1×
Citations per year

Countries citing papers authored by Vivek Nanda

Since Specialization
Citations

This map shows the geographic impact of Vivek Nanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Nanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Nanda more than expected).

Fields of papers citing papers by Vivek Nanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Nanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Nanda. The network helps show where Vivek Nanda may publish in the future.

Co-authors

The 25 scholars most cited alongside Vivek Nanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vivek Nanda Line = papers co-authored together Vivek Nanda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Hit paper breakdown →
2016515
2 2014243
3 2020235
4 201172
5 201546
6 201032
7 201828
8 202425
9 202125
10 202212
11 202011
12 202311
13 201510
14 19976
15 20215
16 20244
17 20224
18 19993
19
Chidambaram: Home of Nataraja
20062
20 20211

About Vivek Nanda

Vivek Nanda is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Emergency Medicine and Political Science and International Relations, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Research and Splicing (3 papers), Coenzyme Q10 studies and effects (3 papers), RNA modifications and cancer (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Single-cell and spatial transcriptomics (2 papers), Global Maritime and Colonial Histories (2 papers), Extracellular vesicles in disease (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Immunology (562 citations), Cancer Research (273 citations), Molecular Biology (552 citations), Immunology and Allergy (31 citations) and Cardiology and Cardiovascular Medicine (109 citations). Vivek Nanda has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Joseph M. Miano, Nicholas J. Leeper, Yoko Kojima, Jianqin Ye, Irving L. Weissman, Ulf Hedin, Lars Mäegdefessel, Thomas Quertermous, Clint L. Miller and Ljubica Matic. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, South Asian Studies, JACC Basic to Translational Science, Nature Nanotechnology and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact